2

Welcome to the Brand page for “2”, which is offered here for Providing medical information relating to the identification in a patient of genetic variations affecting drug action and the development of pharmaceutical preparations whose mechanism of action is related to the said genetic variation in the treatment of cancer, proliferative diseases, inflammatory diseases, neurological diseases, or cardiovascular diseases;.

Its status is currently believed to be active. Its class is unavailable. “2” is believed to be currently owned by “Variagenics, Inc.”